Table 5B.

Genotype of the rs662 polymorphism and serum lipid levels in the longevity and two control groups.

Group	n	TC (mmol/L)	TG (mmol/L)	HDL-c (mmol/L)	LDL-c (mmol/L)
GG
Longevity	43	4.94±1.25	1.56±1.02	1.37±0.63	2.87±0.80
Control 1	59	4.67±1.00	1.46±0.77	1.31±0.57	2.66±0.69
Control 2	70	4.86±2.07	2.41±1.62	0.94±0.12	2.55±1.01
F-value	–	0.849	3.781	2.173	1.122
P-value	–	0.430	0.025	0.117	0.328
AG
Longevity	51	4.97±0.90	1.55±1.08	1.80±0.97	2.75±0.61
Control 1	42	4.49±0.92	1.52±0.91	1.34±0.99	2.64±0.78
Control 2	35	4.90±1.07	1.93±0.61	1.08±0.26	2.42±0.69
F-value	–	3.165	2.528	4.080	0.948
P-value	–	0.046	0.084	0.019	0.390
AA
Longevity	16	4.66±1.18	1.35±0.73	1.42±0.61	2.64±0.74
Control 1	9	5.22±0.94	1.99±0.81	1.48±0.42	2.91±1.26
Control 2	5	4.83±0.99	2.06±0.74	1.08±0.26	2.41±0.58
F-value	–	0.580	1.842	1.914	0.298
P-value	–	0.567	0.179	0.168	0.744
GG+AG
Longevity	94	4.96±1.07	1.56±1.04	1.60±0.86	2.80±0.70
Control 1	101	4.60±0.97	1.48±0.83	1.32±0.77	2.66±0.73
Control 2	105	4.86±1.01	2.02±0.70	1.08±0.26	2.41±0.62
F-value	–	3.263	5.679	6.157	1.876
P-value	–	0.040	0.004	0.002	0.155